surmount-osa trial tirzepatide results on obstructive sleep apnea-related cardiometabolic risk: secondary outcomes of the randomized Tirzepatide after intensive lifestyle intervention
Pay in 4 interest-free payments of $6.40 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28





















